Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated Dr. Divya Colin29 Jun 2025 1:00 PM ISTNew Delhi: Intas Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Coaxial SIL Drains Less Painful Yet Equally Effective as PVC Drains after video-assisted thoracoscopic surgery lung resections: Study Dr. Kamal Kant Kohli27 Jun 2025 9:15 PM ISTA new study has confirmed that coaxial silicone (SIL) drains, due to their softer material, result in less patient discomfort while providing...
AstraZeneca-Daiichi Sankyo Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancer Ruchika Sharma26 Jun 2025 11:20 AM ISTCambridge: AstraZeneca and Daiichi Sankyo have announced that Datroway (datopotamab deruxtecan or Dato-DXd) has...
Talc or Minocycline Pleurodesis May Aid managing malignant pleural effusion Management in Lung Cancer with ILD: Study Dr. Kamal Kant Kohli15 Jun 2025 9:00 PM ISTResearchers have found in a new study that Pleurodesis using talc or minocycline had potential as a treatment option for managing malignant pleural...
New Nanoparticles Therapy for Patients with Lung Cancer, Cystic Fibrosis: Study Finds Dr. Bhumika Maikhuri14 Jun 2025 8:15 AM ISTNew Delhi: For treating respiratory diseases, scientists have developed a new drug delivery system that transports genetic therapies directly to the...
Bristol Myers Squibb, BioNTech ink pact to co-develop, co-commercialize investigational bispecific antibody for multiple solid tumor types Ruchika Sharma6 Jun 2025 11:30 AM ISTPrinceton: BioNTech SE and Bristol Myers Squibb have announced that the companies have entered into an agreement for the global...
Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancer Ruchika Sharma31 May 2025 3:18 PM ISTRahway: Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, have announced that the Biologics License Application...
Early-Stage Lung Cancer Linked to Nodular Wall Thickening in Cystic Lung Lesions: Study Jacinthlyn Sylvia30 May 2025 8:30 PM ISTA recent study published in the journal of Radiology revealed that certain imaging features of cystic lung lesions, specifically those with nodular...
Bayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer Ruchika Sharma29 May 2025 11:15 AM ISTBerlin: Bayer has received Priority Review status from the US Food and Drug Administration (FDA) for the investigational compound sevabertinib...
Deep learning can predict lung cancer risk from single LDCT scan, finds study Dr. Kamal Kant Kohli27 May 2025 9:00 PM ISTA deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS...
Pfizer strikes cancer drug deal with China's 3SBio Ruchika Sharma20 May 2025 11:30 AM IST3SBio plans to initiate the first Phase 3 study in China in 2025.
Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer Ruchika Sharma18 May 2025 2:30 PM ISTBasel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining...
